By: Joel Dudley, Mount Sinai School of Medicine
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
Call Girls Darjeeling Just Call 9907093804 Top Class Call Girl Service Available
SILS 2015 - Connecting Precision Medicine to Precision Wellness
1. Connecting Precision Medicine
to Precision Wellness towards a
systems understanding of
health and disease
Joel Dudley, PhD
Director of Biomedical Informatics &
Associate Professor of Genetics and Genomic
Sciences, Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at
Mount Sinai @IcahnInstitute
2. Mount Sinai Health System
>6,000
Physicians
7
Member hospital campuses
>3,500
>3,100,000
Patient visits
Hospital beds
3. “The future is already here — it's
just not very evenly distributed”.
- William Gibson
8. We must embrace complexity to fully
understand patient physiology and disease
“A complex adaptive system has three characteristics.
The first is that the system consists of a number of
heterogeneous agents, and each of those agents makes
decisions about how to behave. The most important
dimension here is that those decisions will evolve over
time. The second characteristic is that the agents
interact with one another. That interaction leads to the
third—something that scientists call emergence: In a
very real way, the whole becomes greater than the sum
of the parts. The key issue is that you can’t really
understand the whole system by simply looking at its
individual parts”.
- Michael J. Mauboussin (investment banker)
11. Being masters of really big data is now critical
for biomedical research (TB→PB→EB→ZB)
Organisms Tissues Single cells
Single cell,
real-time,
continuous?
13. Redefining the system of human disease with data
~300 Diseases
and Conditions
20k+ Genes
Blue: gene goes
down in disease
Yellow: gene goes up
in disease
14. Redefining the system of human disease with data
Suthram S, Dudley J et al. Network-based elucidation of human disease similarities reveals common functional
modules enriched for pluripotent drug targets. PLoS Computational Biology (2010)
Figure 2. Significant disease-disease similarities. (A)Hierarchical clustering of thediseasecorrelations.Thedistancebetweentwo disease
defined to be(1-correlation coefficient) of thetwo diseases. Thetree wasconstructed using theaverage method of hierarchical clustering. Th
line corresponds to a p-value of 0.01 and FDRof 10.37%and, disease correlations below this line are considered significant. The different c
15. Unexpected connection: anticonvulsant drug treats
inflammatory bowel disease
• TNBS chemically
induced rat model of
IBD
• Animals treated with
80mg/kg topiramate
oral after
sensitization
• Prednisolone positive
control (approved for
IBD in humans)
Dudley, J. T., Sirota, M., et al. (2011). Computational Repositioning of the Anticonvulsant Topiramate for
Inflammatory Bowel Disease. Science Translational Medicine, 3(96).
16. Control Imipramine
Unexpected connection: antipsychotic drug treats small cell
lung cancer
p53/Rb/p130
triple knockout
model of SCLC
Mice dosed
after
tumor
formation
17. Kidd BA, Wroblewska A, Agudo J, Merad M, Brown BD, Dudley JT. Systematic integrative analysis of immune pharmacology. (2015)
Nature Biotechnology. in press.
How do approved drugs modulate networks
in immune cells?
18. Antifungal activates neutrophil migration
Drug A
Drug B
Drug A
Drug A Drug B
Drug A Drug B
Drug A Drug B
Kidd BA, Wroblewska A, Agudo J, Merad M, Brown BD, Dudley JT. Systematic integrative analysis of
immune pharmacology. (2015) Nature Biotechnology. in press.
19. Antifungal activates neutrophil migration
Drug A
Drug B
Drug A
Drug A Drug B
Drug A Drug B
Drug A Drug B
Kidd BA, Wroblewska A, Agudo J, Merad M, Brown BD, Dudley JT. Systematic integrative
analysis of immune pharmacology. (2015) Nature Biotechnology. in press.
20. Immunemod score predicts immune cell
perturbations in patient populations
Kidd BA, Wroblewska A, Agudo J, Merad M, Brown BD, Dudley JT. Systematic integrative analysis of immune pharmacology. (2015)
Nature Biotechnology. in press.
39. 1. Drug A
2. Drug B
3. Drug C
4. Tolfenamic Acid
5. Drug D
6. Drug E
7. …
SP1
NDMN Network Model
Drugs perturbing SP1 sub-
network towards healthy
prioritized by network activity
The network as the target
40. Web-scale deep computing as the future of
medicine and research
http://www.bbc.com/news/technology-18595351
41. Web-scale deep computing as the future of
medicine and research
Xiong et al. Science 9 January 2015
42. Consumer health
tools as a driver
of data-driven
healthcare
Where will most
of the health
data be in 5-10
years?
43. We can embrace digital health and sensors to map the
human phoneme and envirome
48. We need to collect “long” dynamic data
for Precision Wellness
49. In the future you will have coordinates instead of a diagnosis
Topol EJ. Individualized Medicine from Prewomb to Tomb Cell 157, March 27, 2014
50. The emergence of science- and data-driven wellness
info@precisionwellness.org
51. The emergence of science- and data-driven wellness
info@precisionwellness.org
Digital Health
Molecular Profiling
Data Science
Clinical Medicine
The Harris Center for Precision Wellness
www.precisionwellness.org
52.
53. “The future is already here — it's
just not very evenly distributed”.
- William Gibson